Free Trial
NYSEARCA:BOUT

Innovator IBD Breakout Opportunities ETF (BOUT) Price, Holdings, & News

$36.91 -0.32 (-0.87%)
As of 01:04 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT)

Key Stats

Today's Range
$36.85
$37.32
50-Day Range
$34.94
$37.94
52-Week Range
$31.08
$42.41
Volume
815 shs
Average Volume
2,057 shs
Market Capitalization
$11.07 million
Assets Under Management
$11.23 million
Dividend Yield
0.60%
Net Expense Ratio
0.85%
Aggregate Rating
Moderate Buy

ETF Overview

Innovator IBD Breakout Opportunities ETF Expenses

TypeBOUTStrategy ETFsEquity ETFsNYSEARCA ETFsAll ETFs
Management Fee0.80%0.47%0.56%0.51%0.53%
Other Expenses0.05%0.49%0.56%0.59%0.56%
Total Expense0.85%0.67%0.76%0.74%0.73%
Fee Waiver0.00%-0.59%-0.66%-0.71%-0.63%
Net Expense0.85%0.53%0.63%0.58%0.60%
Receive BOUT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Innovator IBD Breakout Opportunities ETF and its competitors with MarketBeat's FREE daily newsletter.

BOUT ETF News Headlines

Trump’s national nightmare is here
Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.
See More Headlines

BOUT ETF - Frequently Asked Questions

Innovator IBD Breakout Opportunities ETF's stock was trading at $39.07 at the beginning of 2025. Since then, BOUT shares have decreased by 5.8% and is now trading at $36.81.

Top institutional investors of Innovator IBD Breakout Opportunities ETF include Comprehensive Money Management Services LLC (9.88%) and Nova Wealth Management Inc. (1.66%).

Shares of BOUT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Innovator IBD Breakout Opportunities ETF investors own include NVIDIA (NVDA), ARK Innovation ETF (ARKK), CRISPR Therapeutics (CRSP), Carvana (CVNA), Fastly (FSLY), Luckin Coffee (LKNCY) and Cloudflare (NET).

Fund Details

Issuer
Innovator Capital Management
Fund Name
Innovator IBD Breakout Opportunities ETF
Tax Classification
Regulated Investment Company
Stock Exchange
NYSEARCA
Current Symbol
NYSEARCA:BOUT
Inception Date
9/13/2018
Fund Manager
Dustin Lewellyn, Ernesto Tong, Anand Desai
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
IBD Breakout Stocks Index
Category
Broad Equity
Focus
Strategy
Development Level
Developed Markets
Region
North America
Number of Holdings
139

Fund Statistics

Assets Under Management
$11.25 million
Average Daily Volume
$1.67 thousand
Discount/Premium
-0.06%

Administrator, Advisor and Custodian

Administrator
U.S. Bancorp Fund Services, LLC
Advisor
Innovator Capital Management, LLC
Custodian
U.S. Bank, N.A.
Distributor
Foreside Fund Services, LLC
Transfer Agent
U.S. Bank, N.A.
Trustee
N/A
Lead Market Maker
Virtu Financial

Options

Optionable
N/A
Short Interest
100 shs

Miscellaneous

Beta
0.98
Creation Unit
50,000
Creation Fee
$250.00
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

Top 10 BOUT Holdings

BOUT Sector Exposure

BOUT Industry Exposure


This page (NYSEARCA:BOUT) was last updated on 8/5/2025 by MarketBeat.com Staff
From Our Partners